Reducing Urban Cervical Cancer Disparities
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-90
SponsorFox Chase Cancer Center
About this trial
This study uses a hybrid Type 1 effectiveness-implementation trial to operationalize and assess the efficacy of the Health Enhancement Resource System (HERS) intervention. HERS aims to increase patient follow-up after abnormal test results through text message-based barriers counseling for women and supplemental telephone-based Health Coaching for women who miss their appointment.
Eligibility criteria
Qualifiers
18 to 90 years of age (screening is still recommended for some women over 65-depending on screening and medical history and proceeds until age 90 in the study's clinic recruitment sites),
referral for colposcopic evaluation at the clinic sites,
able to communicate with ease in English,
have a cell phone with texting ability, and
Disqualifiers
are pregnant at the time of recruitment,
display current evidence or have a history of positive invasive carcinoma of the cervix, or
require follow-up but not a colposcopy.
Trial design
Treatments tested in this trial
- Stage 1 SOC
- Stage 1 HERS
- Stage 2 HERS
- Stage 2 HERS+HC
- Stage 3 SOC
- Stage 3 HERS
- Stage 3 HERS+HC
- Stage 4 HERS
- Stage 4 HERS+HC
Treatment groups
546 Participants
are divided into 13 treatment groups13
Treatment groupsSee each treatment group below.
Sponsors and collaborators
Fox Chase Cancer Center
Lead sponsor
Rutgers, The State University of New Jersey
Collaborator
Thomas Jefferson University
Collaborator
Temple University
Collaborator
University of South Carolina
Collaborator
Source ClinicalTrials.gov